
Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
Related News and Success stories.
-
17 Jul 2025
Grifols invests €160 million in Barcelona and creates 400 jobs with a new plasma fractionation plant
-
14 Jul 2025
Video game multinational Scopely opens its new tech hub in Barcelona, employing 700 people
-
10 Jul 2025
German multinational Fischer invests €4 million to automate and digitalize its logistics center in Catalonia
-
08 Jul 2025
Chinese battery manufacturer Kage opens its European headquarters in Barcelona